AstraZeneca sets up clinical data insights division in India

The Bengaluru-based clinical data and insights (CDI) division is a critical advancement to support a growing global portfolio and build on internal data expertise, the drug firm said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aSRk9o
via IFTTT

0 comments:

Post a Comment